Future Market Insights Global Anti-Infective Vaccines Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016ʹ2026 www.futuremarketinsights.com sales@futuremarketinsights.com RepoorrttDDesecsrcirpitipotinon Rapidly spreading infectious diseases such as tuberculosis, malaria, Hepatitis B, HIV/AIDS, influenza and others are becoming major concern to the society and the healthcare professionals as they are majorly contributing to worldwide causes of death and presenting huge burden on healthcare systems. Infectious diseases are treated with category of drugs including antivirals and anti-infective agents along with adjunct therapy of immune system boosters. Anti-infective vaccines are the most powerful health measure taken by the healthcare systems to prevent the rapidly spreading infectious diseases. Infectious diseases being a substantial health threat, numerous companies are trying to innovate novel anti-infective vaccines to combat patient burden on medical managements. Anti-infective vaccines for the prophylaxis of diseases such as influenza (Fluarix, Fluzone, FluMist), hepatitis (Recombivax HB, Havrix, Engerix-B), malaria (RTS,S), polio (IPOL), tuberculosis (BCG) are readily available in market. Anti- infective vaccines for some infectious diseases such as polio and tetanus are given to child after birth under the national immunization programs.
Global Anti-Infective Vaccines Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2016–2026
www.futuremarketinsights.com
sales@futuremarketinsights.com
RepoorrttDDesecsrcirpitipotinon
Rapidly spreading infectious diseases such as tuberculosis, malaria, Hepatitis B, HIV/AIDS, influenza and others are becoming major concern to the society and the healthcare professionals as they are majorly contributing to worldwide causes of death and presenting huge burden on healthcare systems. Infectious diseases are treated with category of drugs including antivirals and anti-infective agents along with adjunct therapy of immune system boosters. Anti-infective vaccines are the most powerful health measure taken by the healthcare systems to prevent the rapidly spreading infectious diseases. Infectious diseases being a substantial health threat, numerous companies are trying to innovate novel anti-infective vaccines to combat patient burden on medical managements. Anti-infective vaccines for the prophylaxis of diseases such as influenza (Fluarix, Fluzone, FluMist), hepatitis (Recombivax HB, Havrix, Engerix-B), malaria (RTS,S), polio (IPOL), tuberculosis (BCG) are readily available in market. Anti- infective vaccines for some infectious diseases such as polio and tetanus are given to child after birth under the national immunization programs.
Anti-infective vaccines Market: Drivers and Restraints Increasing incidence of infectious diseases, incidence of new emerging diseases, bioterrorism and resistance to existing anti-infective therapies are the major drivers for the growth of global anti-infective vaccines market. Moreover, growing awareness for infectious disease diagnosis, increasing health consciousness, advancements in medical technology, thriving demands for control on infectious diseases are some other factors expected to flourish the growth of global anti-infective vaccines market. However, unavailability of anti-infective vaccines in some
RepoorrttDDesecsrcipritipotinon
underdeveloped regions and high prizes of immunization can be the hurdles in the growth of global anti-infective vaccines market.
Anti-infective vaccines Market: Segmentation The global anti-infective vaccines market has been segmented on the basis of product type, disease type end users and geography. Based on product type, the global anti-infective vaccines market is segmented into following: • Live/attenuated Vaccines • Inactivated Vaccines • DNA & recombinant vector Vaccines • Others (subunit, conjugate, toxoid vaccines)
Visit For TOC@http://www.futuremarketinsights.com/toc/rep-gb-1353
Based on the distribution channel, the global anti-infective vaccines market is segmented into the following: • Hospitals Clinics • Public Hospitals • Private Clinics • Retail Pharmacies and Drug Stores • e-commerce
Anti-infective vaccines Market: Overview The global anti-infective vaccines market possesses a high growth potential owing to ongoing researches and studies by government as well as research institutes for the development of prophylactic vaccines for various infectious diseases. Market for viral diseases vaccines is likely to hold major share in global anti-infective vaccines market due to threat of treating the disease.
RepoorrttDDesecsrcirpitipotinon
Government vaccination centers end user segment majorly contributes to the global anti-infective vaccines market volume due to strong patient pool towards national immunization programs.
Anti-infective vaccines Market: Regional Wise Outlook Geographically, the global anti-infective vaccines market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America anti-infective vaccines market is estimated to lead the global anti-infective vaccines market due to existence of highly planned healthcare reimbursement schemes and higher purchasing power for expensive vaccines. Additionally, APAC and MEA anti-infective vaccines market are expected to grow rapidly during the forecast period because of rising national healthcare expenditure and urge to prevent the spread of infectious diseases
Anti-infective vaccines Market: Key Players Some of the major players in the global anti-infective vaccines market are Barr Labs, Inc., Emergent BioDefense Operations Lansing Inc., Organon Teknika Corp LLC, Sanofi Pasteur, Inc., GlaxoSmithKline Biologicals, Merck & Co, Inc., CSL Limited, MedImmune LLC, ID Biomedical Corp., Novartis Vaccines and Diagnostics Limited, Protein Sciences Corporation, Intercell Biomedical, Wyeth Pharmaceuticals, Inc., MassBiologics, Berna Biotech, Ltd. and others. Numerous companies such as GlaxoSmithKline Pharmaceuticals Ltd., VaxGen etc. are engaged in the development of HIV vaccines which are expected to launch in near future.
Customized Research
Syndicated Research
Investment Research
Social Media Research
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing–the perfect solution for our client. Research Sector Coverage Capabilities Automotive and TransportationChemicals & Materials Customized Research Electronics, Semiconductor, and ICTFood and Beverages Syndicated Research Retail and Consumer ProductsServices and Utilities Investment Research Industrial Automation and EquipmentEnergy, Mining, Oil, and Social Media Research GasHealthcare, Pharmaceuticals & Medical Devices Subscription Information
For detailed subscription information please contact
Hari. T (Sr. Manager - Global Business Development)
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Email: hari.t@futuremarketinsights.com
Thank You!
To know more about us, please visit our website: www.futuremarketinsights.com
For sales queries or new topics email us on: sales@futuremarketinsights.com
For other queries contact: Future Market Insights616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 | D: +1-845-579-5705